Compositions and methods for diagnosis and treatment of cancer
AssigneeBioNTech SE
InventorsUgur Sahin, Bonny Gaby Lui, Nadja Salomon, Joycelyn Wüstehube-Lausch, Matin Daneschdar, Hans-Ulrich Schmoldt, Markus Fiedler
Life of this patent
Estimating the term…
Abstract
The present invention relates to the diagnosis and treatment of diseases expressing Fibronectin Extra Domain B (EDB) such as diseases characterized by tissue remodeling and/or angiogenesis, in particular cancerous diseases, such as head and neck, brain, colorectal, lung, prostate and breast cancer. More particularly, the invention concerns peptides targeting Fibronectin Extra Domain B.
Claims13
A recombinant nucleic acid encoding a Fibronectin Extra Domain B (EDB) binding peptide, wherein said peptide comprises the amino acid sequence:
- (SEQ ID NO:
- 4)
- (Xaa)n1 Cys(Xaa)n2 Arg Ile/Val Arg Leu(Xaa)n3
- Cys(Xaa)n4 Cys(Xaa)n5 Cys (Xaa)n6 Cys(Xaa)n7
- Cys(Xaa)n8,
- wherein
- the Cys residues form a cystine knot structure,
- each Xaa is independently any amino acid, and n1, n2, n3, n4, n5, n6, n7, and n8 are the respective numbers of amino acids, wherein
- n1 is 0 to 4,
- n2 is 3 to 10,
- n3 is 0 to 3,
- n4 is 3 to 7,
- n5 is 2 to 6,
- n6 is 1 to 3,
- n7 is 3 to 7, and
- n8 is 0 to 4, and
- each amino acid Xaa and the number of amino acids n1, n2, n3, n4, n5, n6, n7 and n8 are selected such that a cystine knot structure can form between the Cys residues;
- and wherein the recombinant nucleic acid is in the form of a vector or RNA.
Dependencies are inferred from the claim text.